{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:53:39Z","timestamp":1791230019520,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008696","name":"University of the Punjab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12346-0","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:42:02Z","timestamp":1784266922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SLC25A1 drives lipid metabolic reprogramming promoting liver injury leading to hepatocellular carcinoma"],"prefix":"10.1007","volume":"53","author":[{"given":"Mehak","family":"Shahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isbah","family":"Ashfaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burhan","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-3740","authenticated-orcid":false,"given":"Asima","family":"Tayyeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"12346_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/biom11020141","volume":"11","author":"R Mosaoa","year":"2021","unstructured":"Mosaoa R, Kasprzyk-Pawelec A, Fernandez HR, Avantaggiati ML (2021) The Mitochondrial Citrate Carrier SLC25A1\/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond. Biomolecules 11:141","journal-title":"Biomolecules"},{"key":"12346_CR2","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/s41418-020-0491-6","volume":"27","author":"M Tan","year":"2020","unstructured":"Tan M, Mosaoa R, Graham T, Kasprzyk-awelec A, Gadre S, Parasido E, Avantaggiati L (2020) Inhibition of the mitochondrial citrate carrier, SLC25A1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD\/NASH. Cell Death Differ 27:2143\u20132157","journal-title":"Cell Death Differ"},{"key":"12346_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12672-023-00830-z","volume":"14","author":"X You","year":"2023","unstructured":"You X, Huang L, Huang O, Deng Y, Shi X (2023) A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancer. Discover Oncol 14:207","journal-title":"Discover Oncol"},{"issue":"12","key":"12346_CR4","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41419-021-04411-2","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang Y, He J, Zhang B, Zhang Z, Jia G, Liu S, Wu T, He X, Wang N (2021) SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer. Cell Death Dis 12(12):1108","journal-title":"Cell Death Dis"},{"issue":"11","key":"12346_CR5","doi-asserted-by":"publisher","first-page":"e0837","DOI":"10.1097\/HC9.0000000000000837","volume":"9","author":"TL Wong","year":"2025","unstructured":"Wong TL, Kong Y, Ma S (2025) Lipid metabolism in cancer cells: Its role in hepatocellular carcinoma progression and therapeutic resistance. Hepatol Commun 9(11):e0837","journal-title":"Hepatol Commun"},{"key":"12346_CR6","first-page":"1","volume":"3","author":"S Park","year":"2025","unstructured":"Park S, Hall MN (2025) Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications. Exp Mol Med 3:1\u20139","journal-title":"Exp Mol Med"},{"key":"12346_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"40","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A (2022) Hepatocellular carcinoma. Lancet 40:1345\u20131362","journal-title":"Lancet"},{"key":"12346_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B (2023) Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev 42:629\u2013652","journal-title":"Cancer Metastasis Rev"},{"key":"12346_CR9","first-page":"145","volume":"31","author":"J Arnbjerg","year":"1979","unstructured":"Arnbjerg J (1979) Klinisk anvendelse af ketamine-xylazine til bed\u00f8velse af katte [Clinical use of ketamine-xylazine for anaesthesia in the cat (author\u2019s transl)]. Nord Vet Med 31:145\u2013154","journal-title":"Nord Vet Med"},{"key":"12346_CR10","unstructured":"Kiernan J (2015) Histological and histochemical methods. Scion publishing ltd. Jun 8"},{"key":"12346_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/0003-9861(83)90073-5","volume":"225","author":"KE Crow","year":"1983","unstructured":"Crow KE, Braggins TJ, Hardman MJ (1983) Human liver cytosolic malate dehydrogenase: purification, kinetic properties, and role in ethanol metabolism. Arch Biochem Biophys 225:621\u2013629","journal-title":"Arch Biochem Biophys"},{"key":"12346_CR12","volume-title":"Methods of enzymatic analysis","author":"HU Bergmeyer","year":"1974","unstructured":"Bergmeyer HU (1974) Methods of enzymatic analysis, 2nd edn. Academic, New York","edition":"2"},{"key":"12346_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R et al (2025) Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target therapy 10:35","journal-title":"Signal Transduct Target therapy"},{"key":"12346_CR14","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1002\/cpz1.211","volume":"8","author":"T Uehara","year":"2021","unstructured":"Uehara T, Pogribny IP, Rusyn I (2021) The DEN and CCl4-induced mouse model of fibrosis and inflammation\u2010associated hepatocellular carcinoma. Curr protocols 8:e211","journal-title":"Curr protocols"},{"key":"12346_CR15","doi-asserted-by":"publisher","first-page":"1601215","DOI":"10.3389\/fimmu.2025.1601215","volume":"16","author":"A Ajith","year":"2025","unstructured":"Ajith A, Evraerts J, Bouzin C, Brusa D, Merimi M, Najar M et al (2025) Progression to fibrosis and hepatocellular carcinoma in DEN CCl4 liver mice, is associated with macrophage and striking regulatory T cells infiltration. Front Immunol 16:1601215","journal-title":"Front Immunol"},{"key":"12346_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/biology12040595","volume":"12","author":"R Amorim","year":"2023","unstructured":"Amorim R, Magalh\u00e3es CC, Borges F, Oliveira PJ, Teixeira J (2023) From non-alcoholic fatty liver to Hepatocellular Carcinoma: A Story of (Mal) adapted Mitochondria. Biology 12:595","journal-title":"Biology"},{"key":"12346_CR17","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/cancers13071599","volume":"13","author":"Y Cho","year":"2021","unstructured":"Cho Y, Cho EJ, Yoo JJ, Chang Y, Chung GE, Jeong SM et al (2021) Association between lipid profiles and the incidence of hepatocellular carcinoma: a nationwide population-based study. Cancers 13:1599","journal-title":"Cancers"},{"key":"12346_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2013.05.030","volume":"59","author":"D Beyo\u011flu","year":"2013","unstructured":"Beyo\u011flu D, Idle JR (2013) The metabolomic window into hepatobiliary disease. J Hepatol 59:842\u2013858","journal-title":"J Hepatol"},{"key":"12346_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.18632\/genesandcancer.203","volume":"11","author":"A Tripathy","year":"2020","unstructured":"Tripathy A, Thakurela S, Sahu MK, Uthansingh K, Singh A, Narayan J et al (2020) Fatty changes associated with N-Nitrosodiethylamine (DEN) induced hepatocellular carcinoma: a role of sonic hedgehog signaling pathway. Genes Cancer 11:66","journal-title":"Genes Cancer"},{"key":"12346_CR20","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.cmet.2023.09.012","volume":"35","author":"AR Terry","year":"2023","unstructured":"Terry AR, Nogueira V, Rho H, Ramakrishnan G, Li J, Kang S et al (2023) CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression. Cell Metabol 35:2060\u20132076","journal-title":"Cell Metabol"},{"key":"12346_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41420-025-02558-x","volume":"11","author":"J Xi","year":"2025","unstructured":"Xi J, Lei S, Chen J, Liu J, Shan C, Sun X et al (2025) Killing hepatocellular carcinoma in the NAFLD\/NASH stage: a comprehensive perspective on targeting regulated cell death. Cell Death Discovery 11:281","journal-title":"Cell Death Discovery"},{"key":"12346_CR22","first-page":"1","volume":"66","author":"G Zhang","year":"2025","unstructured":"Zhang G, Wu J, Ji M, Liu X, Shi M (2025) SLC25A1 promotes lymph node metastasis of esophageal squamous cell carcinoma by regulating lipid metabolism. Int J Oncol 66:1\u20134","journal-title":"Int J Oncol"},{"key":"12346_CR23","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52:1836\u20131846","journal-title":"Hepatology"},{"key":"12346_CR24","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.3390\/cancers12082276","volume":"12","author":"Z Nouri","year":"2020","unstructured":"Nouri Z, Fakhri S, Nouri K, Wallace CE, Farzaei MH, Bishayee A (2020) Targeting multiple signaling pathways in cancer: The rutin therapeutic approach. Cancers 12:2276","journal-title":"Cancers"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12346-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:42:04Z","timestamp":1784266924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12346-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12346"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12346-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have consented to participate in this publication.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1188"}}